Ka-Vit Tropfen

Phytomenadione, the active ingredient in Ka-Vit Tropfen, is a Vitamin K presented as oral drops for oral use. It supports normal blood clotting by addressing vitamin K deficiency and is employed in newborns to prevent hemorrhage and in patients requiring reversal of oral anticoagulant therapy.

GNH USA supplies Ka-Vit Tropfen as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides regulatory documentation for global distribution. Customers benefit from reliable logistics, temperature-controlled shipping where required, and responsive technical support.

Ka-Vit Tropfen (phytomenadione) is used to correct impaired coagulation associated with vitamin K–dependent pathways.

- Vitamin K deficiency: restores activity of clotting factors II, VII, IX and X. - Newborn hemorrhage prevention: provides prophylactic vitamin K to reduce risk of bleeding in infants. - Reversal of oral anticoagulant therapy: counteracts the effect of warfarin and similar agents to re‑establish normal clotting.

Adverse reactions may occur with oral vitamin K administration.

Common Side Effects: - Nausea: mild to moderate stomach upset. - Vomiting: occasional emesis after dosing. - Diarrhea: loose stools in some patients. - Abdominal pain: transient discomfort. - Headache: mild tension‑type headache. - Skin rash: mild erythema or pruritus.

Serious or Rare Side Effects: - Anaphylaxis: severe allergic reaction requiring immediate medical attention. - Hemolysis: rare destruction of red blood cells. - Elevated liver enzymes: possible hepatic irritation. - Thrombosis: uncommon formation of abnormal clots. - Severe hypersensitivity: including angioedema. - Hyperbilirubinemia: rare increase in bilirubin levels.

Before using Ka-Vit Tropfen, consider the following precautions.

- Pregnancy: safety not established; use only if potential benefit justifies the risk. - Breastfeeding: unknown excretion in milk; evaluate risk versus benefit. - Renal impairment: monitor clotting status closely. - Concomitant anticoagulants: may reduce anticoagulant efficacy; adjust therapy as needed. - Bleeding disorders: assess baseline coagulation before administration. - Store at ambient temperature: keep in the original container, protect from moisture and light.

Phytomenadione may interact with several medicines.

Major Interactions (Avoid): - Warfarin: antagonizes anticoagulant effect, potentially leading to clotting. - Broad‑spectrum antibiotics (e.g., cephalosporins): reduce intestinal vitamin K synthesis, diminishing efficacy. - Bile‑acid sequestrants: decrease absorption of oral vitamin K.

Moderate Interactions (Monitor Closely): - Vitamin K supplements: may alter therapeutic response. - Heparin: additive effect on clotting parameters. - Oral contraceptives: possible increased risk of thrombosis when combined with high vitamin K levels.